参考文献
1: Roche E, Lascombe I, Bittard H, Mougin C, Fauconnet S. The PPARβ agonist
L-165041 promotes VEGF mRNA stabilization in HPV18-harboring HeLa cells through a
receptor-independent mechanism. Cell Signal. 2014 Feb;26(2):433-43. doi:
10.1016/j.cellsig.2013.10.006. Epub 2013 Oct 28. PubMed PMID: 24172859.
2: Park JH, Lee KS, Lim HJ, Kim H, Kwak HJ, Park HY. The PPARδ ligand L-165041
inhibits VEGF-induced angiogenesis, but the antiangiogenic effect is not related
to PPARδ. J Cell Biochem. 2012 Jun;113(6):1947-54. doi: 10.1002/jcb.24063. PubMed
PMID: 22234939.
3: Lim HJ, Park JH, Lee S, Choi HE, Lee KS, Park HY. PPARdelta ligand L-165041
ameliorates Western diet-induced hepatic lipid accumulation and inflammation in
LDLR-/- mice. Eur J Pharmacol. 2009 Nov 10;622(1-3):45-51. doi:
10.1016/j.ejphar.2009.09.002. Epub 2009 Sep 18. PubMed PMID: 19766624.
4: Lim HJ, Lee S, Park JH, Lee KS, Choi HE, Chung KS, Lee HH, Park HY. PPAR delta
agonist L-165041 inhibits rat vascular smooth muscle cell proliferation and
migration via inhibition of cell cycle. Atherosclerosis. 2009 Feb;202(2):446-54.
doi: 10.1016/j.atherosclerosis.2008.05.023. Epub 2008 May 21. PubMed PMID:
18585719.
